Organisation paid for research Program year 2022 Source: CMS Open Payments

Altus Research, Inc.

Neither a doctor nor a teaching hospital

Research payments

$258,413

7 payments

Through program year 2022, Altus Research, Inc. is reported as receiving $258,413 in research payments, across 7 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2022	Research	$99,654	1
2021	Research	$20,901	1
2020	Research	$133,896	2
2019	Research	$3,961	3

Breakdown

Who paid Research payments · program years 2019–2022

Amgen Inc. $120,555 2 payments
Exeltis, USA Inc. $83,271 1 payment
Becton, Dickinson and Company $50,625 1 payment
Merck Sharp & Dohme Corporation $3,961 3 payments

Studies the money was for Research payments · program years 2019–2022

P3 switching study PK; plaque psoriasis $99,654 1 payment
A Pivotal, Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, Tolerability ofLPRI-424, 13 Cycles $83,271 1 payment
HPV Biospec $50,625 1 payment
Interchangeability Study - ABP 654 $20,901 1 payment
A 52-Week, Phase 3, Randomized, Active Comparator and Placebo-Controlled, Parallel Design Study to Evaluate the Efficacy and Safety,Tolerability of Subcutaneous SCH 900222,MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Subjects With Moderate-to-Severe Chronic Plaque Psoriasis Protocol NO. MK-3222-011 $3,961 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.